Biodesix Total Assets from 2010 to 2025

BDSX Stock

USD 0.85 0 0.47%

Biodesix Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets will likely drop to about 89.1 M in 2025. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2019-12-31

Previous Quarter

102.7 M

Current Value

97.2 M

Quarterly Volatility

23.4 M

Covid

Check Biodesix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biodesix's main balance sheet or income statement drivers, such as Interest Income of 25.9 K, Depreciation And Amortization of 3.2 M or Interest Expense of 6.9 M, as well as many indicators such as Price To Sales Ratio of 2.64, Dividend Yield of 0.0 or PTB Ratio of 7.36. Biodesix financial statements analysis is a perfect complement when working with Biodesix Valuation or Volatility modules.

Check out the analysis of Biodesix Correlation against competitors.

For more information on how to buy Biodesix Stock please use our How to Invest in Biodesix guide.

Latest Biodesix's Total Assets Growth Pattern

Below is the plot of the Total Assets of Biodesix over the last few years. Total assets refers to the total amount of Biodesix assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Biodesix books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Biodesix's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biodesix's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 97.24 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Biodesix Total Assets Regression Statistics

	Arithmetic Mean	60,542,199
	Geometric Mean	54,725,620
	Coefficient Of Variation	48.84
	Mean Deviation	26,534,499
	Median	39,057,000
	Standard Deviation	29,569,077
	Sample Variance	874.3T
	Range	82M
	R-Value	0.79
	Mean Square Error	354.6T
	R-Squared	0.62
	Significance	0.0003
	Slope	4,896,267
	Total Sum of Squares	13115T

Biodesix Total Assets History

	2025	89.1 M
	2024	97.2 M
	2023	99.1 M
	2022	92.9 M
	2021	76.1 M
	2020	121.1 M
	2019	41.6 M

Other Fundumenentals of Biodesix

Intangibles To Total Assets

Biodesix Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Intangible Assets	Common Stock	Property Plant Equipment	Short Long Term Debt	Short Term Debt	Deferred Long Term Liab
Total Assets		0.96	0.96	0.62	-0.33	-0.79	0.76	0.17	0.9	0.93	-0.93	0.97	0.95	0.75	0.82	-0.85	0.75	0.79	-0.72	-0.71	-0.39
Total Stockholder Equity	0.96		1.0	0.54	-0.34	-0.84	0.6	0.1	0.76	0.96	-0.99	1.0	0.91	0.8	0.77	-0.89	0.8	0.84	-0.85	-0.84	-0.46
Net Tangible Assets	0.96	1.0		0.52	-0.33	-0.84	0.6	0.13	0.76	0.96	-0.99	1.0	0.9	0.8	0.75	-0.89	0.8	0.84	-0.86	-0.85	-0.45
Current Deferred Revenue	0.62	0.54	0.52		-0.74	-0.12	0.87	-0.54	0.76	0.46	-0.51	0.52	0.8	0.07	0.73	-0.21	0.07	0.09	-0.09	-0.1	-0.02
Net Debt	-0.33	-0.34	-0.33	-0.74		-0.21	-0.53	0.76	-0.3	-0.17	0.38	-0.3	-0.56	0.26	-0.63	-0.07	0.26	0.18	-0.02	-0.04	-0.42
Retained Earnings	-0.79	-0.84	-0.84	-0.12	-0.21		-0.27	-0.52	-0.58	-0.9	0.81	-0.86	-0.61	-0.99	-0.43	0.97	-0.99	-0.99	0.92	0.92	0.73
Accounts Payable	0.76	0.6	0.6	0.87	-0.53	-0.27		-0.16	0.93	0.53	-0.55	0.61	0.85	0.24	0.8	-0.35	0.24	0.24	-0.12	-0.13	-0.08
Long Term Debt	0.17	0.1	0.13	-0.54	0.76	-0.52	-0.16		0.12	0.26	-0.07	0.15	-0.1	0.57	-0.14	-0.48	0.57	0.54	-0.32	-0.31	-0.37
Net Receivables	0.9	0.76	0.76	0.76	-0.3	-0.58	0.93	0.12		0.76	-0.7	0.78	0.9	0.56	0.79	-0.64	0.56	0.56	-0.4	-0.4	-0.34
Good Will	0.93	0.96	0.96	0.46	-0.17	-0.9	0.53	0.26	0.76		-0.95	0.97	0.83	0.87	0.67	-0.96	0.87	0.89	-0.88	-0.87	-0.53
Total Liab	-0.93	-0.99	-0.99	-0.51	0.38	0.81	-0.55	-0.07	-0.7	-0.95		-0.98	-0.88	-0.76	-0.75	0.88	-0.76	-0.81	0.87	0.86	0.4
Net Invested Capital	0.97	1.0	1.0	0.52	-0.3	-0.86	0.61	0.15	0.78	0.97	-0.98		0.91	0.82	0.76	-0.9	0.82	0.86	-0.85	-0.84	-0.49
Total Current Assets	0.95	0.91	0.9	0.8	-0.56	-0.61	0.85	-0.1	0.9	0.83	-0.88	0.91		0.57	0.9	-0.68	0.57	0.62	-0.58	-0.56	-0.28
Capital Stock	0.75	0.8	0.8	0.07	0.26	-0.99	0.24	0.57	0.56	0.87	-0.76	0.82	0.57		0.44	-0.93	1.0	0.98	-0.87	-0.86	-0.8
Net Working Capital	0.82	0.77	0.75	0.73	-0.63	-0.43	0.8	-0.14	0.79	0.67	-0.75	0.76	0.9	0.44		-0.49	0.44	0.45	-0.36	-0.33	-0.24
Intangible Assets	-0.85	-0.89	-0.89	-0.21	-0.07	0.97	-0.35	-0.48	-0.64	-0.96	0.88	-0.9	-0.68	-0.93	-0.49		-0.93	-0.96	0.93	0.92	0.56
Common Stock	0.75	0.8	0.8	0.07	0.26	-0.99	0.24	0.57	0.56	0.87	-0.76	0.82	0.57	1.0	0.44	-0.93		0.98	-0.87	-0.86	-0.8
Property Plant Equipment	0.79	0.84	0.84	0.09	0.18	-0.99	0.24	0.54	0.56	0.89	-0.81	0.86	0.62	0.98	0.45	-0.96	0.98		-0.92	-0.9	-0.69
Short Long Term Debt	-0.72	-0.85	-0.86	-0.09	-0.02	0.92	-0.12	-0.32	-0.4	-0.88	0.87	-0.85	-0.58	-0.87	-0.36	0.93	-0.87	-0.92		0.99	0.53
Short Term Debt	-0.71	-0.84	-0.85	-0.1	-0.04	0.92	-0.13	-0.31	-0.4	-0.87	0.86	-0.84	-0.56	-0.86	-0.33	0.92	-0.86	-0.9	0.99		0.54
Deferred Long Term Liab	-0.39	-0.46	-0.45	-0.02	-0.42	0.73	-0.08	-0.37	-0.34	-0.53	0.4	-0.49	-0.28	-0.8	-0.24	0.56	-0.8	-0.69	0.53	0.54

Click cells to compare fundamentals

About Biodesix Financial Statements

Biodesix investors use historical fundamental indicators, such as Biodesix's Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biodesix. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	97.2 M	89.1 M
Intangibles To Total Assets	0.21	0.42

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Biodesix Stock Analysis

When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC